Fundraising Fox

Constructive Bio

Founded 2021 · 71 employees on LinkedIn · 10 known investors

Constructive Bio is a biotechnology company that rewrites the genetic code to give cells access to non-canonical amino acid building blocks, expanding the range of proteins that can be designed, engineered, and manufactured. Its platform aims to move novel molecules from research to industrial-scale production for applications ranging from medicines to advanced materials.

Founders & leadership

Constructive Bio was founded in 2021 by Jason Chin.

JCJason Chin
Jason ChinProfessor

Investors · 10

Also in the syndicate · 1

Fine Structure Ventures

Funding

SEC filings, press & company announcements

$58M disclosed across 1 round · 2024

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Constructive Bio do?
Constructive Bio is a biotechnology company that rewrites the genetic code to give cells access to non-canonical amino acid building blocks, expanding the range of proteins that can be designed, engineered, and manufactured. Its platform aims to move novel molecules from research to industrial-scale production for applications ranging from medicines to advanced materials.
Who founded Constructive Bio?
Constructive Bio was founded by Jason Chin in 2021.
Who are Constructive Bio's investors?
Constructive Bio's investors include +ND Capital, Amadeus Capital Partners, Fine Structures Ventures, GENERAL INCEPTION, LongeVC, OMX Ventures, Paladin Capital Group, Ahren and 1 more.
How much funding has Constructive Bio raised?
Constructive Bio has disclosed $58M raised across 1 round.